The information in this section is intended for visitors outside the United States.
FOSTER CITY, Calif.--(BUSINESS WIRE)--Feb. 7, 2017--
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Board of
Directors declared an increase of 10% in the company’s quarterly cash
dividend, beginning in the first quarter of 2017. The dividend increase
will result in a quarterly dividend of $0.52 per share of common stock.
The dividend is payable on March 30, 2017, to stockholders of record at
the close of business on March 16, 2017. Future dividends will be
subject to Board approval.
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases. Gilead has operations in more than 30
countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s
website at www.gilead.com,
follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs
at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170207006271/en/
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.InvestorsRobin
Washington, 650-522-5688Sung Lee, 650-524-7792